FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant’s Biz StrategyNews DeskAugust 28, 20260 Treatment for dermatomyositis has not changed in decades, which makes a new FDA approval particularly meaningful for patients who have…